Secretion of inflammatory mediators by isolated rat Kupffer cells: The effect of octreotide

Regulatory Peptides

Volumn 120, Issue 1-3, 2004, Pages 215-225

  Valatas, Vassilis ^a   Kolios, George ^a   Manousou, Pinelopi ^a   Xidakis, Costas ^a   Notas, George ^a   Ljumovic, Dusanka ^a   Kouroumalis, Elias A ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Inflammation; Liver sinusoidal cells; LPS; Neuropeptide(s); Somatostatin

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OCTREOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOSTATIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL STIMULATION; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; KUPFFER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-6; KUPFFER CELLS; NITRIC OXIDE; OCTREOTIDE; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642574850     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.03.009     Document Type: Article

References (61)

1. Reichlin S. Somatostatin. Engl. N. J. Med. 309:1983;1495-1501
2. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc. Natl. Acad. Sci. U. S. A. 95:1998;12544-12549
3. Peluso G., Petillo O., Melone M.A., Mazzarella G., Ranieri M., Tajana G.F. Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides. 30:1996;443-451
4. van Hagen P.M., Hofland L.J., ten Bokum A.M., Lichtenauer-Kaligis E.G., Kwekkeboom D.J., Ferone D., et al. Neuropeptides and their receptors in the immune system. Ann. Med. 31(Suppl. 2):1999;15-22
5. Dickerson C., Undem B., Bullock B., Winchurch R.A. Neuropeptide regulation of proinflammatory cytokine responses. J. Leukoc. Biol. 63:1998;602-605
6. Patel Y.C. Somatostatin and its receptor family. Front. Neuroendocrinol. 20:1999;157-198
7. McIntosh C.H. Gastrointestinal somatostatin: distribution, secretion and physiological significance. Life Sci. 37:1985;2043-2058
8. ten Bokum A.M., Hofland L.J., van Hagen P.M. Somatostatin and somatostatin receptors in the immune system: a review. Eur. Cytokine Netw. 11:2000;161-176
9. Karalis K., Mastorakos G., Chrousos G.P., Tolis G. Somatostatin analogues suppress the inflammatory reaction in vivo. J. Clin. Invest. 93:1994;2000-2006
10. Lamberts S.W., van der Lely A.J., de Herder W.W., Hofland L.J. Octreotide. N. Engl. J. Med. 334:1996;246-254
11. Kouroumalis E., Skordilis P., Thermos K., Vasilaki A., Moschandrea J., Manousos O.N. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut. 42:1998;442-447
12. Kusterer K., Blochle C., Konrad T., Palitzsch K.D., Usadel K.H. Rat liver injury induced by hypoxic ischemia and reperfusion: protective action by somatostatin and two derivatives. Regul. Pept. 44:1993;251-256
13. Landa I., Arias J., Gomez M., Quadros M., Moreno A., Balibrea J.L. Cytoprotective effect of somatostatin in a rat model of hepatic ischemic reperfusion. Hepatology. 16:1992;1474-1476
14. Myren J., Bang S., Linnestad P., Stave R., Hanssen L.E., Dolva L.O., et al. Liver cell necrosis and regeneration following injections of carbon tetrachloride. Effects of the thyrotropin-releasing hormone and somatostatin. APMIS. 97:1989;334-342
15. Limberg B., Kommerell B. Beneficial effect of somatostatin on galactosamine induced liver injury. Regul. Pept. 7:1983;187-193
16. Chatterjee S., Mbaye A., De Man J.G., Van Marck E.A. Does the neuropeptide somatostatin have therapeutic potential against schistosomiasis? Trends Parasitol. 18:2002;295-298
17. von Frankenberg M., Golling M., Mehrabi A., Nentwich H., Klar E., Kraus T.W. Donor pretreatment with gadolinium chloride improves early graft function and survival after porcine liver transplantation. Transpl. Int. 16:2003;806-813
18. Stachlewitz R.F., Seabra V., Bradford B., Bradham C.A., Rusyn I., Germolec D., et al. Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells. Hepatology. 29:1999;737-745
19. Muriel P., Escobar Y. Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride. J. Appl. Toxicol. 23:2003;103-108
20. Kojima Y., Suzuki S., Tsuchiya Y., Konno H., Baba S., Nakamura S. Regulation of pro-inflammatory and anti-inflammatory cytokine responses by Kupffer cells in endotoxin-enhanced reperfusion injury after total hepatic ischemia. Transpl. Int. 16:2003;231-240
21. Hines I.N., Hoffman J.M., Scheerens H., Day B.J., Harada H., Pavlick K.P., et al. Regulation of postischemic liver injury following different durations of ischemia. Am. J. Physiol. Gastrointest. Liver Physiol. 284:2003;G536-G545
22. Sass G., Koerber K., Bang R., Guehring H., Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 107:2001;439-447
23. Hayashi N., Matsui K., Tsutsui H., Osada Y., Mohamed R.T., Nakano H., et al. Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens. J. Immunol. 163:1999;6702-6711
24. Valatas V., Kolios G., Manousou P., Notas G., Xidakis C., Diamantis I., et al. Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells. Br. J. Pharmacol. 141:2004;477-487
25. Valatas V., Xidakis C., Roumpaki H., Kolios G., Kouroumalis E.A. Isolation of rat Kupffer cells: a combined methodology for highly purified primary cultures. Cell Biol. Int. 27:2003;67-73
26. Sass G., Koerber K., Bang R., Guehring H., Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J. Clin. Invest. 107:2001;439-447
27. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902
28. Matrella E., Valatas V., Notas G., Roumpaki H., Xidakis C., Hadzidakis A., et al. Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease. Aliment. Pharmacol. Ther. 15:2001;857-864
29. Jordan N.J., Kolios G., Abbot S.E., Sinai M.A., Thompson D.A., Petraki K., et al. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J. Clin. Invest. 104:1999;1061-1069
30. Chowers Y., Cahalon L., Lahav M., Schor H., Tal R., Bar-Meir S., et al. Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. J. Immunol. 165:2000;2955-2961
31. Smedsrod B., De Bleser P.J., Braet F., Lovisetti P., Vanderkerken K., Wisse E., et al. Cell biology of liver endothelial and Kupffer cells. Gut. 35:1994;1509-1516
32. Bradham C.A., Plumpe J., Manns M.P., Brenner D.A., Trautwein C. Mechanisms of hepatic toxicity: I. TNF-induced liver injury. Am. J. Physiol. 275:1998;G387-G392
33. Callery M.P., Kamei T., Flye M.W. Endotoxin stimulates interleukin-6 production by human Kupffer cells. Circ. Shock. 37:1992;185-188
34. Aldeguer X., Debonera F., Shaked A., Krasinkas A.M., Gelman A.E., Que X., et al. Interleukin-6 from intrahepatic cells of bone marrow origin is required for normal murine liver regeneration. Hepatology. 35:2002;40-48
35. Seki S., Habu Y., Kawamura T., Takeda K., Dobashi H., Ohkawa T., et al. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses [In Process Citation]. Immunol. Rev. 174:2000;35-46
36. Matsukawa A., Hogaboam C.M., Lukacs N.W., Lincoln P.M., Evanoff H.L., Strieter R.M., et al. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164:2000;2738-2744
37. Hayashi N., Matsui K., Tsutsui H., Osada Y., Mohamed R.T., Nakano H., et al. Kupffer cells from Schistosoma mansoni-infected mice participate in the prompt type 2 differentiation of hepatic T cells in response to worm antigens. J. Immunol. 163:1999;6702-6711
38. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van Dyke T., Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167:2001;5067-5076
39. Thompson K., Maltby J., Fallowfield J., McAulay M., Millward-Sadler H., Sheron N. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology. 28:1998;1597-1606
40. Nadler E.P., Dickinson E.C., Beer-Stolz D., Alber S.M., Watkins S.C., Pratt D.W., et al. Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G173-G181
41. Mustafa S.B., Olson M.S. Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J. Biol. Chem. 273:1998;5073-5080
42. Beck K.F., Eberhardt W., Frank S., Huwiler A., Messmer U.K., Muhl H., et al. Inducible NO synthase: role in cellular signalling. J. Exp. Biol. 202:1999;645-653
43. Chao T.C., Chao H.H., Lin J.D., Chen M.F. Somatostatin and octreotide modulate the function of Kupffer cells in liver cirrhosis. Regul. Pept. 79:1999;117-124
44. Chao T.C., Chao H.H., Chen M.F., Lin J.D. Somatostatin modulates the function of Kupffer cells. Regul. Pept. 69:1997;143-149
45. Setyono-Han B., Henkelman M.S., Foekens J.A., Klijn G.M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 47:1987;1566-1570
46. de Jong M., Breeman W.A., Bernard B.F., van Gameren A., de Bruin E., Bakker W.H., et al. Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3] octreotide is dependent on the peptide amount. Eur. J. Nucl. Med. 26:1999;693-698
47. Kubota A., Yamada Y., Kagimoto S., Shimatsu A., Imamura M., Tsuda K., et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J. Clin. Invest. 93:1994;1321-1325
48. Carruthers A.M., Warner A.J., Michel A.D., Feniuk W., Humphrey P.P. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins. Br. J. Pharmacol. 126:1999;1221-1229
49. Suk K., Erickson K.L. Differential regulation of tumour necrosis factor-alpha mRNA degradation in macrophages by interleukin-4 and interferon-gamma. Immunology. 87:1996;551-558
50. Zuckerman S.H., Evans G.F., Guthrie L. Transcriptional and post-transcriptional mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunology. 73:1991;460-465
51. Medina D.L., Toro M.J., Santisteban P. Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and cyclin E×cyclin-dependent kinase 2 complexes. J. Biol. Chem. 275:2000;15549-15556
52. Sakanaka C., Ferby I., Waga I., Bito H., Shimizu T. On the mechanism of cytosolic phospholipase A2 activation in CHO cells carrying somatostatin receptor: Wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 205:1994;18-23
53. Wright K., Ward S.G., Kolios G., Westwick J. Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J. Biol. Chem. 272:1997;12626-12633
54. Kolios G., Brown Z., Robson R.L., Robertson D.A., Westwick J. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br. J. Pharmacol. 116:1995;2866-2872
55. Komorowski J., Jankiewicz-Wika J., Stepien T., Kuzdak K., Stepien H. Octreotide inhibits the secretion of interleukin-12 from mononuclear cells in human peripheral blood (PBMCs) in vitro. Horm. Metab. Res. 33:2001;689-690
56. Su G.L. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 283:2002;G256-G265
57. Kusterer K., Blochle C., Konrad T., Palitzsch K.D., Usadel K.H. Rat liver injury induced by hypoxic ischemia and reperfusion: protective action by somatostatin and two derivatives. Regul. Pept. 44:1993;251-256
58. Bloechle C., Kusterer K., Konrad T., Hosch S.B., Izbicki J.R., Knoefel W.T., et al. Rat liver injury induced by hypoxic ischemia and reperfusion: protective action by somatostatins is independent from changes in glucose metabolism. Horm. Metab. Res. 26:1994;270-275
59. Mansy S.S., Yehia H.A., Hassan M.M., Hassan E.A., Youssef M.M., Hadi A.A., et al. Octreotide decreases connective tissue formation and improves vascular changes associated with hepatic schistosomiasis. J. Egypt Soc. Parasitol. 28:1998;23-44
60. Fort J., Oberti F., Pilette C., Veal N., Gallois Y., Douay O., et al. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology. 28:1998;1525-1531
61. Tracy T.F. Jr., Tector A.J., Goerke M.E., Kitchen S., Lagunoff D. Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction. Am. J. Pathol. 143:1993;1574-1578